Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population

Diabetes

Volumn 61, Issue 12, 2012, Pages 3314-3321

  Gamboa Meléndez, Marco Alberto ^a   Huerta Chagoya, Alicia ^a   Moreno Macías, Hortensia ^a,b   Vázquez Cárdenas, Paola ^a   Ordóñez Sánchez, María Luisa ^a   Rodríguez Guillén, Rosario ^a   Riba, Laura ^a   Rodríguez Torres, Maribel ^a   Guerra García, María Teresa ^a   Guillén Pineda, Luz Elizabeth ^c   Choudhry, Shweta ^d   Del Bosque Plata, Laura ^e   Canizales Quinteros, Samuel ^a   Pérez Ortiz, Gustavo ^a   Escobedo Aguirre, Fernando ^f   Parra, Adalberto ^g   Lerman Garber, Israel ^c   Aguilar Salinas, Carlos Alberto ^c   Tusié Luna, María Teresa ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^f Hospital 20 de Noviembre   (Mexico)

^g INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS9 PROTEIN; ARHGEF11 PROTEIN; BIOLOGICAL MARKER; CDC123 PROTEIN; CDKAL1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FTO PROTEIN; HHEX PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; JAZF1 PROTEIN; KCNQ1 PROTEIN; NOTCH2 RECEPTOR; NXPH1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RALGPS2 PROTEIN; RETINOID RELATED ORPHAN RECEPTOR ALPHA; SLC30A8 PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; THADA PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; TSPAN8 PROTEIN; UBQLNL PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CATION TRANSPORT PROTEINS; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; KCNQ1 POTASSIUM CHANNEL; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION FACTORS;

EID: 84870311448     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0550     Document Type: Article

References (47)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
2. Villalpando S, de la Cruz V, Rojas R, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Publica Mex 2010;52(Suppl. 1):S19-S26
3. Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus en adultos mexicanos. Resultados de la Encuesta Nacional de Salud 2000. Salud Publica Mex 2007;49:1-7
4. Jiménez-Corona A, Rojas R, Gómez-Pérez FJ, Aguilar-Salinas CA. Earlyonset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010;52(Suppl. 1):S27-S35
5. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, et al. Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med 2002;113:569-574 (Pubitemid 35379912)
6. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885
7. Saxena R, Voight BF, Lyssenko V, et al; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336
8. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345 (Pubitemid 46871655)
9. Zeggini E, Weedon MN, Lindgren CM, et al Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336-1341 (Pubitemid 46871654)
10. Zeggini E, Scott LJ, Saxena R, et al Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008;40:638-645 (Pubitemid 351601209)
11. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092-1097
12. Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008;40:1098-1102
13. Hayes MG, Pluzhnikov A, Miyake K, et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 2007;56:3033-3044 (Pubitemid 350223640)
14. Groves CJ, Zeggini E, Minton J, et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006;55:2640-2644 (Pubitemid 44871167)
15. Scott LJ, Bonnycastle LL, Willer CJ, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006;55:2649-2653 (Pubitemid 44871169)
16. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia 2007;50:747-751 (Pubitemid 46355825)
17. Parra EJ, Cameron E, Simmonds L, et al. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City. Clin Genet 2007;71:359-366 (Pubitemid 46680802)
18. Cruz M, Valladares-Salgado A, Garcia-Mena J, et al. Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City. Diabetes Metab Res Rev 2010;26:261-270
19. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 2010;1212:59-77
20. Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010;16:407-416
21. Omori S, Tanaka Y, Takahashi A, et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008;57:791-795
22. Gutiérrez-Vidal R, Rodríguez-Trejo A, Canizales-Quinteros S, et al. LOC387761 polymorphism is associated with type 2 diabetes in the Mexican population. Genet Test Mol Biomarkers 2011;15:79-83
23. Price AL, Patterson N, Yu F, et al. A genomewide admixture map for Latino populations. Am J Hum Genet 2007;80:1024-1036 (Pubitemid 47579340)
24. Villarreal-Molina MT, Flores-Dorantes MT, Arellano-Campos O, et al Metabolic Study Group. Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population. Diabetes 2008;57:509-513
25. Encuesta Nacional de Salud 2000. La Salud de los Adultos Tomo II. Cuernavaca, Morelos, México, Instituto Nacional de Salud Pública, 2000
26. Frayling TM, Wiltshire S, Hitman GA, et al. Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. Diabetes 2003;52:1857-1863 (Pubitemid 36792479)
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
28. Ma L, Hanson RL, Que LN, et al; International Type 2 Diabetes 1q Consortium. Variants in ARHGEF11, a candidate gene for the linkage to type 2 diabetes on chromosome 1q, are nominally associated with insulin resistance and type 2 diabetes in Pima Indians. Diabetes 2007;56:1454-1459 (Pubitemid 46715622)
29. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945-959 (Pubitemid 30397141)
30. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164:1567-1587 (Pubitemid 37102217)
31. Weissglas-Volkov D, Calkin AC, Tusie-Luna T, et al. The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans. J Clin Invest 2011;121:3062-3071
32. Selvin S. Statistical Analysis of Epidemiologic Data. Oxford, New York, Oxford University Press, 2004
33. Tabara Y, Osawa H, Kawamoto R, et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009;58:493-498
34. Omori S, Tanaka Y, Horikoshi M, et al. Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals. Diabetologia 2009;52:1554-1560
35. Parra EJ, Below JE, Krithika S, et al. Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas. Diabetologia 2011;54:2038-2046.
36. Grarup N, Rose CS, Andersson EA, et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007;56:3105-3111 (Pubitemid 350223649)
37. Qi L, Parast L, Cai T, et al. Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J Am Coll Cardiol 2011;58:2675-2682
38. Stancáková A, Pihlajamäki J, Kuusisto J, et al.; EUGENE2 Consortium. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J Clin Endocrinol Metab 2008;93:1924-1930 (Pubitemid 351656539)
39. Florez JC, Jablonski KA, Bayley N, et al.; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-250 (Pubitemid 44079339)
40. Florez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care 2007;10:391-396 (Pubitemid 46934105)
41. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007;117:2155-2163 (Pubitemid 47219560)
42. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007;39:770-775 (Pubitemid 46848592)
43. Pascoe L, Tura A, Patel SK, et al.; RISC Consortium; U.K. Type 2 Diabetes Genetics Consortium. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007;56:3101-3104 (Pubitemid 350223648)
44. Cauchi S, Nead KT, Choquet H, et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008;9:45
45. Imamura M, Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. Endocr J 2011;58:723-739
46. del Bosque-Plata L, Aguilar-Salinas CA, Tusié-Luna MT, et al. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metab 2004;81:122-126 (Pubitemid 38096379)
47. Villalobos-Comparán M, Teresa Flores-Dorantes M, Teresa Villarreal-Molina M, et al. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring) 2008;16:2296-2301